+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Proton-dependent inhibition of the cardiac sodium channel Nav1.5 by ranolazine

Proton-dependent inhibition of the cardiac sodium channel Nav1.5 by ranolazine

Frontiers in Pharmacology 4: 78

Ranolazine is clinically approved for treatment of angina pectoris and is a potential candidate for antiarrhythmic, antiepileptic, and analgesic applications. These therapeutic effects of ranolazine hinge on its ability to inhibit persistent or late Na(+) currents in a variety of voltage-gated sodium channels. Extracellular acidosis, typical of ischemic events, may alter the efficiency of drug/channel interactions. In this study, we examined pH modulation of ranolazine's interaction with the cardiac sodium channel, Nav1.5. We performed whole-cell path clamp experiments at extracellular pH 7.4 and 6.0 on Nav1.5 transiently expressed in HEK293 cell line. Consistent with previous studies, we found that ranolazine induced a stable conformational state in the cardiac sodium channel with onset/recovery kinetics and voltage-dependence resembling intrinsic slow inactivation. This interaction diminished the availability of the channels in a voltage- and use-dependent manner. Low extracellular pH impaired inactivation states leading to an increase in late Na(+) currents. Ranolazine interaction with the channel was also slowed 4-5 fold. However, ranolazine restored the voltage-dependent steady-state availability profile, thereby reducing window/persistent currents at pH 6.0 in a manner comparable to pH 7.4. These results suggest that ranolazine is effective at therapeutically relevant concentrations (10 μM), in acidic extracellular pH, where it compensates for impaired native slow inactivation.

(PDF emailed within 0-6 h: $19.90)

Accession: 055260773

Download citation: RISBibTeXText

PMID: 23801963

DOI: 10.3389/fphar.2013.00078

Related references

State- and use-dependent block of muscle Nav1.4 and neuronal Nav1.7 voltage-gated Na+ channel isoforms by ranolazine. Molecular Pharmacology 73(3): 940-948, 2007

Discovery of triazolopyridinone GS-462808, a late sodium current inhibitor (Late INai) of the cardiac Nav1.5 channel with improved efficacy and potency relative to ranolazine. Bioorganic and Medicinal Chemistry Letters 26(13): 3207-3211, 2017

Extracellular proton modulation of the cardiac voltage-gated sodium channel, Nav1.5. Biophysical Journal 101(9): 2147-2156, 2012

Proton Modulation of Gating Currents in the Cardiac Voltage-Gated Sodium Channel, NaV1.5. Biophysical Journal 102(3): 326a-327a, 2012

Cardiac Sodium Channel: Activation by CaM Involves a NaV1.5-NaV1.5 Interaction. Biophysical Journal 108(2): 127a-128a, 2015

Local-anesthetic like inhibition of the cardiac sodium channel Nav1.5 α-subunit by 5-HT3 receptor antagonists. European Journal of Pharmacology 789: 119-126, 2017

Osteoarthritis-dependent changes in antinociceptive action of Nav1.7 and Nav1.8 sodium channel blockers: An in vivo electrophysiological study in the rat. Neuroscience 295: 103-116, 2016

Calmodulin regulates current density and frequency-dependent inhibition of sodium channel Nav1.8 in DRG neurons. Journal of Neurophysiology 96(1): 97-108, 2006

Calcium-dependent Nedd4-2 upregulation mediates degradation of the cardiac sodium channel Nav1.5: implications for heart failure. Acta Physiologica 221(1): 44-58, 2017

Ca2+/calmodulin-dependent protein kinase II (CaMKII) regulates cardiac sodium channel NaV1.5 gating by multiple phosphorylation sites. Journal of Biological Chemistry 287(24): 19856-19869, 2012

The distinct effects of lipid emulsions used for "lipid resuscitation" on gating and bupivacaine-induced inhibition of the cardiac sodium channel Nav1.5. Anesthesia and Analgesia 117(5): 1101-1108, 2013

L-type calcium channel activation up-regulates the mRNAs for two different sodium channel alpha subunits (Nav1.2 and Nav1.3) in rat pituitary GH3 cells. Brain Research. Molecular Brain Research 116(1-2): 115-125, 2003

The sodium channel Nav1.5a is the predominant isoform expressed in adult mouse dorsal root ganglia and exhibits distinct inactivation properties from the full-length Nav1.5 channel. Molecular and Cellular Neurosciences 35(2): 283-291, 2007

Transmembrane segments prevent surface expression of sodium channel Nav1.8 and promote calnexin-dependent channel degradation. Journal of Biological Chemistry 285(43): 32977-32987, 2010

Cardiac sodium channel Nav1.5 mutations and cardiac arrhythmia. Pediatric Cardiology 33(6): 943-949, 2013